Biogen Inc.
BIIB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000875045
In the last 90 days, Biogen Inc. insiders filed 0 open-market purchases and 1 sale; 1,047 institutions reported holding it in 13F filings for Q2 2026, worth $30.7B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Biogen Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 930 | 12 | 987 | +69 |
| Shares | 121.8M | 12.5K | 123.8M | +1.99M (+1.6%) |
| Value | $25.0B | $2.50M | $33.0B | +$8.02B (+32.1%) |
12 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (149)
Institutions that held Biogen Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Showing the largest 100 of 149 by value.
Sold out (80)
Institutions that held Biogen Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
Not filed for Q3 2022 yet (12)
Institutions that held Biogen Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Advisor Partners LLC | 2,653 | $541.0K |
| Coldstream Capital Management Inc | 2,002 | $408.0K |
| Dixon Hubard Feinour & Brown Inc | 1,841 | $375.0K |
| Brewin Dolphin Ltd | 1,668 | $340.0K |
| Quintet Private Bank (Europe) S.A. | 1,113 | $317.8K |
| Icon Wealth Partners, LLC | 1,356 | $277.0K |
| Intersect Capital LLC | 1,021 | $208.0K |
| Urban Wealth Management, LLC | 124 | $25.0K |
| Private Capital Group, LLC | 54 | $11.0K |
| Fieldpoint Private Securities, LLC | 5 | $1.00K |
| Exane Derivatives | 1 | $204 |
| B. Riley Wealth Management, Inc. | 681 | – |